Bioneutra Internatio Stock Current Valuation
| BIMO Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Bioneutra Internatio helps investors to measure Bioneutra Internatio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 26th of February 2025, Enterprise Value Over EBITDA is likely to drop to -14.48. In addition to that, Enterprise Value Multiple is likely to drop to -14.48. Fundamental drivers impacting Bioneutra Internatio's valuation include:
Overvalued
Today
Please note that Bioneutra Internatio's price fluctuation is very steady at this time. Calculation of the real value of Bioneutra Internatio is based on 3 months time horizon. Increasing Bioneutra Internatio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bioneutra Internatio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioneutra Stock. However, Bioneutra Internatio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Bioneutra Internatio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bioneutra Internatio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bioneutra Internatio helps investors to forecast how Bioneutra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioneutra Internatio more accurately as focusing exclusively on Bioneutra Internatio's fundamentals will not take into account other important factors: Bioneutra Internatio Company Current Valuation Analysis
Bioneutra Internatio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bioneutra Internatio Current Valuation | 16.34 K |
Most of Bioneutra Internatio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioneutra Internatio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bioneutra Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Bioneutra Internatio is extremely important. It helps to project a fair market value of Bioneutra Stock properly, considering its historical fundamentals such as Current Valuation. Since Bioneutra Internatio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bioneutra Internatio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bioneutra Internatio's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bioneutra Internatio has a Current Valuation of 16.34 K. This is 100.0% lower than that of the Industrial Conglomerates sector and 100.0% lower than that of the Industrials industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Bioneutra Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioneutra Internatio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioneutra Internatio could also be used in its relative valuation, which is a method of valuing Bioneutra Internatio by comparing valuation metrics of similar companies.Bioneutra Internatio is currently under evaluation in current valuation category among its peers.
Bioneutra Fundamentals
| Current Valuation | 16.34 K | ||||
| Shares Outstanding | 163.43 M | ||||
| Beta | 3.66 | ||||
| Market Capitalization | 16.34 K |
About Bioneutra Internatio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioneutra Internatio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioneutra Internatio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioneutra Internatio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bioneutra Internatio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioneutra Internatio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioneutra Internatio will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Bioneutra Internatio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioneutra Internatio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioneutra Internatio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioneutra Internatio to buy it.
The correlation of Bioneutra Internatio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioneutra Internatio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioneutra Internatio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioneutra Internatio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bioneutra Internatio Piotroski F Score and Bioneutra Internatio Altman Z Score analysis. To learn how to invest in Bioneutra Stock, please use our How to Invest in Bioneutra Internatio guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Industrial Conglomerates space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioneutra Internatio. If investors know Bioneutra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioneutra Internatio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioneutra Internatio is measured differently than its book value, which is the value of Bioneutra that is recorded on the company's balance sheet. Investors also form their own opinion of Bioneutra Internatio's value that differs from its market value or its book value, called intrinsic value, which is Bioneutra Internatio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioneutra Internatio's market value can be influenced by many factors that don't directly affect Bioneutra Internatio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioneutra Internatio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioneutra Internatio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioneutra Internatio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.